PD08: Kidney Cancer: Epidemiology & Evaluation/Staging/Surveillance I

Podium Session Moderator(s)

• 

  Masatoshi Eto, MD (he/him/his)

  Kyushu University, Department of Urology
• 

  Eric Kauffman, MD

  Roswell Park Comprehensive Cancer Center
• 

  J. Stuart Wolf, Jr, MD

  Dept of Surgery - Exec Assoc Chair; Assoc Chair for Clinical Operations; Chief,
  Dell Medical School of The University of Texas at Austin

Presentations:

• 1:00 PM – 1:10 PM CST

  PD08-01: Financial toxicity in non-metastatic renal cell carcinoma patients
  

  Podium Presenter: Michael D. Staehler, MD (he/him/his) – University of Munich
• 1:10 PM – 1:20 PM CST

  PD08-02: Application of Hospital Frailty Risk Score in Risk Stratifying Elderly Patients Undergoing Nephrectomy in a National Inpatient Database
  

  Podium Presenter: Zhiyu (jason) Qian, MD (he/him/his) – Brigham and Women's Hospital
• 1:20 PM – 1:30 PM CST

  PD08-03: Long-term tumor necrosis factor-alpha inhibitor use increases the risk of Renal Cell Carcinoma
  

  Podium Presenter: Conor Driscoll, MD (he/him/his) – Northwestern Urology
• 1:30 PM – 1:40 PM CST

  PD08-04: Virtual Renal Mass Biopsy: Predicting Renal Tumor Histology on Abdominal CT Images Using Machine Learning
  

  Podium Presenter: Abhinav Khanna, MD (he/him/his) – Mayo Clinic
• 1:40 PM – 1:50 PM CST

  PD08-05: Computer-Generated C-Index Nephrometry Scores Demonstrate Superior Predictive Accuracy to Those of Human-Generated Scores in Predicting Oncologic and Perioperative Outcomes
  

  Podium Presenter: Andrew M. Wood, MD
• 1:50 PM – 2:00 PM CST

  PD08-06: Fully Automated Tumor Contact Surface Area Predicts Postoperative Ipsilateral GFR Preservation Following Partial Nephrectomy
  

  Podium Presenter: Andrew M. Wood, MD
• 2:00 PM – 2:10 PM CST

  PD08-07: Predictive Factors for Recurrence and Outcomes in T1a Renal Cell Carcinoma: Analysis of the INMARC (International Marker Consortium for Renal Cancer) Database
  

  Podium Presenter: Franklin Liu, BS – University of California San Diego
• 2:10 PM – 2:20 PM CST

  PD08-08: Should Adjuvant Therapy be Considered for Positive Surgical Margins in Renal Cell Carcinoma: A Stage-Based Analysis of Impact of Positive Surgical Margins on Survival Outcomes Using the INMARC Registry
  

  Podium Presenter: Margaret Frances Meagher, MD
• 2:20 PM – 2:30 PM CST

  PD08-09: Interim analysis of a national retrospective study of cT3b+ renal cell carcinoma patients’ pulmonary embolism risk and thromboprophylaxis management
  

  Podium Presenter: James Peter Blackmur, MD,PhD
• 2:30 PM – 2:40 PM CST

  PD08-10: Higher classes of Bosniak cysts: A rose with thorns.
  

  Podium Presenter: Ali Mohamed Elmenair Yassen Abed, MSC – Mansoura Urology and Nephrology Center
• 2:40 PM – 2:50 PM CST

  PD08-11: Active Surveillance versus Primary Intervention for Clinical T1a Kidney Tumors: Twelve-Year Experience of the DISSRM Prospective Comparative Study
  

  Podium Presenter: Khalid Alkhatib, MD (he/him/his)
• 2:50 PM – 3:00 PM CST

  PD08-12: Predictors of progression and delayed intervention in small renal mass patients undergoing active surveillance without health-related selection bias
  

  Podium Presenter: Muammer Altok, MD (he/him/his) – Roswell Park Comprehensive Cancer Center